Inhibition of Anaphylaxis by Ibrutinib
Clinical trial NCT03149315 · COMPLETED
Trial details
- NCT number
- NCT03149315
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2018-11-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.